Quality of biological active substances produced by stable transgene expression in higher plants

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberEMEA/CHMP/BWP/48316/2006
Effective from01/02/2009
KeywordsTransgenic plants, molecular farming
DescriptionThis document explains how to achieve satisfactory quality for biological active substances produced using transgenic plant technology. It applies primarily to active substances intended for parenteral administration.

Document history

First version

Current version

Adopted guideline

Overview of comments

Draft guideline

In operation: 01/02/2009–present

Published: 24/07/2008

Published: 19/07/2006

Related content

How helpful is this page?

Average rating:

 Based on 20 ratings

Add your rating:

See all ratings
4 ratings
4 ratings
4 ratings
4 ratings
4 ratings

Tell us more